Evidence map›Paper›PMID 28194657›Full record

ReviewApplied health economics and health policy2017

EQ-5D and the EuroQol Group: Past, Present and Future.

Nancy J Devlin, Richard Brooks

6 registry-linked trialsAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Applied health economics and health policy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 6 registered trials, which are not on this map. Cited by 661 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
661citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04794062 completednot on this mapstarted 2020, after this paper: background citation

Myocardial Injury and Quality of Life in Patients Recovered From the Pneumonia Associated With the Novel Coronavirus Infectious Disease COVID-19

TypeobservationalSponsorVoronezh Regional Clinical Consultative and Diagnostic CenterRan2020 to 2021Enrolled119ConditionsCOVID-19, Myocardial Injury, Myocarditis Post Infection
NCT04915027 narecruitingnot on this mapstarted 2020, after this paper: background citation

Rehabkompassen® - a Novel Digital Tool for Facilitating Patient-tailored Rehabilitation in the Post-acute Continuum of Care After Stroke - A Multicenter Pragmatic Randomized Controlled Trial

TypeinterventionalSponsorUmeå UniversityRan2020 to 2027Enrolled1,106ConditionsStrokeArmsa usual follow-up with Rehabkompassen®, a usual follow-up with Post-Stroke Checklist, i.e. without Rehabkompassen®
NCT05782582 narecruitingnot on this mapstarted 2023, after this paper: background citation

Chronic Coronary Syndrome in Swedish Primary Care

TypeinterventionalSponsorRegion ÖstergötlandRan2023 to 2032Enrolled500ConditionsCoronary Artery DiseaseArmsPackage investigation, Sound registration with Cadscore® and added risk calculation, Standard investigation
NCT05963815 recruitingnot on this mapstarted 2023, after this paper: background citation

Spine Patient Reported Outcome Measures: a Cohort Observational Study

TypeobservationalSponsorPark Medical centrumRan2023 to 2030Enrolled4,000ConditionsLumbar Disc Herniation, Spondylolisthesis, Spinal StenosisArmsSpine surgery
NCT06307210 completednot on this mapstarted 2020, after this paper: background citation

Clinical Effects of Inpatient Rehabilitation in Very Old Patients With Neurological, Musculoskeletal or Geriatric Disorders

TypeobservationalSponsorKlinik ValensRan2020 to 2023Enrolled2,270ConditionsActivity, Motor, Elderly Patients, Musculoskeletal DiseasesArmsinpatient rehabilitation
NCT06568029 completednot on this mapstarted 2024, after this paper: background citation

Construct Validity and Responsiveness of EQ-5D-3L in Patients With Rheumatic Disease

TypeobservationalSponsorKarolinska InstitutetRan2024 to 2024Enrolled77,651ConditionsRheumatoid Arthritis, Polyarthritis, Psoriatic Arthritis, Ankylosing SpondylitisArmsQuestionnaire
3 · Its place in the literature

Who cites it

661 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Quality of life among obstructive sleep apnoea patients: a systematic review and meta-analysis of EQ-5D studies.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025
    Pooled it
  8. Pooled it
  9. Trial
  10. Administration-order effects in head-to-head comparisons of the EQ-5D-3L and EQ-5D-5L descriptive systems: evidence from a randomised general-population panel in Great Britain.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Is episodic future thinking effective in mitigating the influence of time preference in time trade-off?The European journal of health economics : HEPAC : health economics in prevention and care · 2025
    Trial
  18. Trial
  19. Trial
  20. Trial

601 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nancy J DevlinOffice of Health Economics, London, SW1 3QT, UK. ndevlin@ohe.org.
Richard BrooksEuroQol Group, Rotterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the period 1987-1991 an inter-disciplinary five-country group developed the EuroQol instrument, a five-dimensional three-level generic measure subsequently termed the 'EQ-5D'. It was designed to measure and value health status. The salient features of its development and its consolidation and expansion are discussed. Initial expansion came, in particular, in the form of new language versions. Their development raised translation and semantic issues, experience with which helped feed into the design of two further instruments, the EQ-5D-5L and the youth version EQ-5D-Y. The expanded usage across clinical programmes, disease and condition areas, population surveys, patient-reported outcomes, and value sets is outlined. Valuation has been of continued relevance for the Group as this has allowed its instruments to be utilised as part of the economic appraisal of health programmes and their incorporation into health technology assessments. The future of the Group is considered in the context of: (1) its scientific strategy, (2) changes in the external environment affecting the demand for EQ-5D, and (3) a variety of issues it is facing in the context of the design of the instrument, its use in health technology assessment, and potential new uses for EQ-5D outside of clinical trials and technology appraisal.

Indexed as

Quality Indicators, Health CareDelivery of Health CareDiet, HealthyEuropeForecastingHumansQuality Assurance, Health Care

Identifiers

PMID28194657
PMCPMC5343080

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.